NASDAQ:NRC National Research (NRC) Stock Price, News & Analysis $20.43 +0.26 (+1.29%) Closing price 10/14/2026 04:00 PM EasternExtended Trading$20.50 +0.07 (+0.34%) As of 10/14/2026 04:10 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsInsider TradesNews and TrendsOptions ChainOwnershipSEC FilingsShort Interest About National Research Stock (NASDAQ:NRC) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get National Research alerts:Sign Up Key Stats Today's Range$19.97▼$20.4950-Day Range$19.47▼$22.3152-Week Range$11.20▼$23.68Volume78,775 shsAverage Volume117,797 shsMarket Capitalization$464.70 millionP/E Ratio81.72Dividend Yield3.13%Price Target$26.00Consensus RatingHold Company Overview National Research Corporation, formerly traded on the Nasdaq under the symbol NRC and known as NRC Health, provides market research, analytics and performance-improvement services to healthcare organizations. Its solutions are designed to help hospitals, health systems and other providers understand the experiences and expectations of patients, employees, physicians and communities. The company’s offerings have included patient-experience measurement, employee and physician engagement surveys, reputation and brand research, community health assessments, data analytics and advisory services. NRC Health combines survey programs, benchmarking data and technology tools to help healthcare organizations improve service quality, strengthen relationships with stakeholders and support strategic decision-making. Founded in 1981 and headquartered in Lincoln, Nebraska, the company served healthcare organizations in the United States and other markets. National Research Corporation was acquired by Press Ganey in 2021 and became part of Press Ganey’s healthcare experience and improvement platform. The business is now generally identified as NRC Health rather than as an independent publicly traded company.AI Generated. May Contain Errors. Read More National Research Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks78th Percentile Overall ScoreNRC MarketRank™: 3.89005786428 of 5 starsNational Research scored higher than 78% of companies evaluated by MarketBeat, and ranked 169th out of 873 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion3.6 / 5Analyst RatingHold Consensus RatingNational Research has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on no strong buy ratings, 1 buy rating, 1 hold rating, and 1 sell rating.Upside PotentialNational Research has a consensus price target of $26.00, representing about 27.3% upside from its current price of $20.43.Amount of Analyst CoverageNational Research has only been the subject of 3 research reports in the past 90 days.Read more about National Research's stock forecast and price target. Earnings and Valuation1.9 / 5Proj. Earnings Growth7.14% Earnings GrowthEarnings for National Research are expected to grow by 7.14% in the coming year, from $0.98 to $1.05 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of National Research is 81.72, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 35.98.Price to Earnings Ratio vs. SectorThe P/E ratio of National Research is 81.72, which means that it is trading at a less expensive P/E ratio than the Healthcare sector average P/E ratio of about 211.42.Price to Book Value per Share RatioNational Research has a P/B Ratio of 32.95. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.Read more about National Research's valuation and earnings. Short Interest2.0 / 5Short Interest LevelBearish Percentage of Shares Shorted3.32% of the float of National Research has been sold short.Short Interest Ratio / Days to CoverNational Research has a short interest ratio ("days to cover") of 4.98.Change versus previous monthShort interest in National Research has recently increased by 0.04%, indicating that investor sentiment is decreasing. Dividend1.7 / 5Dividend StrengthWeak Dividend YieldNational Research pays a meaningful dividend of 3.14%, higher than the bottom 25% of all stocks that pay dividends.Dividend GrowthNational Research does not have a long track record of dividend growth.Dividend CoverageThe dividend payout ratio of National Research is 256.00%. Payout ratios above 75% are not desirable because they may not be sustainable.Dividend SustainabilityBased on earnings estimates, National Research will have a dividend payout ratio of 60.95% next year. This indicates that National Research will be able to sustain or increase its dividend.Read more about National Research's dividend. News and Social Media3.8 / 5News Sentiment1.09 News SentimentNational Research has a news sentiment score of 1.09. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.71 average news sentiment score of Healthcare companies.News Coverage This WeekMarketBeat has tracked 4 news articles for National Research this week, compared to 1 article on an average week.Search Interest8 people have searched for NRC on MarketBeat in the last 30 days. Company Ownership0.9 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, National Research insiders have not sold or bought any company stock.Percentage Held by Insiders9.20% of the stock of National Research is held by insiders.Percentage Held by Institutions47.26% of the stock of National Research is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about National Research's insider trading history. Receive NRC Stock News and Ratings via Email Sign-up to receive the latest news and ratings for National Research and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. NRC Stock News HeadlinesNational Research (NASDAQ:NRC) Shares Cross Above Two Hundred Day Moving Average - Time to Sell?1 hour ago | americanbankingnews.comOver $135 million invested through NRC IRAP Defence Industry Assist to help Canadian businesses develop defence and dual-use technologies2 hours ago | finance.yahoo.comThe end may be near for these iconic stocksMarc Chaikin, founder of Chaikin Analytics, says two forces - AI disruption and fracturing global trade - are triggering a historic wealth transfer already underway in 2026. Household names like Intuit (-57%), Boston Scientific (-49%), and Tractor Supply (-40%) are cratering, while lesser-known companies like Sandisk (+573%) and Rackspace (+444%) surge. Chaikin has identified specific stocks he believes investors should sell before they fall further - and the names may surprise you. He's also pinpointing a company tapped as Nvidia's self-driving partner and a potential AI megadeal that could split into three high-growth stocks. Stream his free presentation to get every buy and sell recommendation with no membership or credit card required. | Chaikin Analytics (Ad)National Research (NASDAQ:NRC) Raised to "Hold" at Zacks ResearchOctober 7, 2026 | americanbankingnews.comWhat is Citizens Jmp's Estimate for NRC Q3 Earnings?October 6, 2026 | americanbankingnews.comFormer U.S. NRC Commissioner and U.S. DOE Nuclear Chief William D. Magwood, IV to Join newcleo's Board of Directors in January 2027September 30, 2026 | globenewswire.comMercy Earns National Honor for Excellence in Patient ExperienceSeptember 1, 2026 | prnewswire.comRecord Backlog Powers NRC Health’s (NRC) Upward PotentialAugust 10, 2026 | insidermonkey.comSee More Headlines NRC Stock Analysis - Frequently Asked Questions How have NRC shares performed this year? National Research's stock was trading at $18.77 at the start of the year. Since then, NRC shares have increased by 8.8% and is now trading at $20.43. How were National Research's earnings last quarter? National Research Corporation (NASDAQ:NRC) issued its quarterly earnings data on Tuesday, July, 28th. The company reported $0.31 earnings per share for the quarter, beating analysts' consensus estimates of ($0.15) by $0.46. The business had revenue of $35.39 million for the quarter, compared to analyst estimates of $34.90 million. National Research had a net margin of 4.18% and a trailing twelve-month return on equity of 164.26%. Read the conference call transcript. Does National Research have any subsidiaries? National Research subsidiaries include these companies: PatientWisdom Inc., The Governance Institute, and National Research Corporation Canada. How do I buy shares of National Research? Shares of NRC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of National Research own? Based on aggregate information from My MarketBeat watchlists, some other companies that National Research investors own include Marvell Technology (MRVL), Micron Technology (MU), Cronos Group (CRON), Cisco Systems (CSCO), First Majestic Silver (AG), Arista Networks (ANET) and Applied Materials (AMAT). Company Calendar Last Earnings7/28/2026Record date for 10/9 Dividend9/25/2026Ex-Dividend for 10/9 Dividend9/25/2026Dividend Payable10/09/2026Today10/14/2026Next Earnings (Estimated)10/26/2026Fiscal Year End12/31/2026Get Stock Alerts Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Green Zone (7m+) 1-Year History Oct 25 Jan 26 Apr 26 Jul 26 Oct 26 NRC's financial health is in the Green zone, according to TradeSmith. NRC has been in this zone for over 7 months. Industry, Sector and Symbol Stock ExchangeNASDAQ SectorHealthcare Industry Healthcare Technology Sub-IndustryHealthcare Technology Current SymbolNASDAQ:NRC CIK70487 Webwww.nrchealth.com Phone(402) 475-2525Fax402-475-9061Employees357Year Founded1981Price Target and Rating Average Price Target for National Research$26.00 High Price Target$26.00 Low Price Target$26.00 Potential Upside/Downside+27.3%Consensus RatingHold Rating Score (0-4)2.00 Research Coverage3 Analysts Profitability EPS (Trailing Twelve Months)$0.25 Trailing P/E Ratio81.72 Forward P/E Ratio20.85 P/E GrowthN/ANet Income$11.60 million Net Margins4.18% Pretax Margin6.70% Return on Equity164.26% Return on Assets14.67% Debt Debt-to-Equity Ratio13.13 Current Ratio0.65 Quick Ratio0.65 Sales & Book Value Annual Sales$140.00 million Price / Sales3.32 Cash Flow$1.27 per share Price / Cash Flow16.04 Book Value$0.62 per share Price / Book32.95Miscellaneous Outstanding Shares22,746,000Free Float20,653,000Market Cap$464.70 million OptionableOptionable Beta0.25 Social Links (Almost) Everything You Need To Know About The EV MarketLooking to profit from the electric vehicle mega-trend? Click the link to see our list of which EV stocks show the most long-term potential.Get This Free Report This page (NASDAQ:NRC) was last updated on 10/14/2026 by MarketBeat.com Staff. From Our PartnersALERT: Drop these 5 stocks before the market opens tomorrow!The Wall Street Journal is already raising the alarm about a potential market crash, and Weiss Ratings researc...Weiss Ratings | SponsoredTrump's New DollarPorter Stansberry says President Trump has signed an executive order initiating what he calls a full U.S. doll...Porter & Company | SponsoredSmall Colorado Company (Backed by Sam Altman) Could Save U.S. Power GridA small Colorado company has secured rights to technology that could prevent the U.S. public power grid from c...Altimetry | SponsoredReady to give options a try? Your first trade (Ticker included) -INSIDETired of trying tactic after tactic when it comes to options trades... only to be met with market noise and st...Base Camp Trading | SponsoredThe end may be near for these iconic stocksMarc Chaikin, founder of Chaikin Analytics, says two forces - AI disruption and fracturing global trade - are ...Chaikin Analytics | SponsoredLouis Navellier: My #1 AI stock for 2026 (name & ticker inside)Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top...InvestorPlace | SponsoredHere’s the stock symbol I’ve promisedWhitney Tilson of Stansberry Research has long recommended Berkshire Hathaway as a core retirement holding - b...Stansberry Research | SponsoredBank of America: 'Digital Dollar Inevitable'Bank of America just revealed your expiration date. In their Bloomberg interview, they didn't just predict the...Decentralized Masters | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding National Research Corporation Please log in to your account or sign up in order to add this asset to your watchlist. Share National Research With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
